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Although numerous materials have been explored as bone scaffolds, many of them are limited by 
their low osteoconductivity and a high biodegradability. Therefore, new materials are desired to 
induce bone cell proliferation and facilitate the bone formation. Attapulgite (ATP) is a hydrated silicate 
that exists in nature as a fibrillar clay mineral and is well known for its large specific surface area, 
high viscosity, and high absorption capacity, therefore has the potential to be a new type of bone 
repair material due to its unique physicochemical properties. In this study, composite scaffolds 
composed of collagen/polycaprolactone/attapulgite (CPA) or collagen/polycaprolactone (CP) were 
fabricated through a salt-leaching method. The morphology, composition, microstructure, physical 
and mechanical characteristics of the CPA and CP scaffolds were assessed. Cells from the mouse 
multipotent mesenchymal precursor cell line (D1 cells) were cocultured with the scaffolds, and cell 
adhesion, proliferation, and gene expression on the CPA and CP scaffolds were analyzed. Adult 
rabbits with radius defects were used to evaluate the performance of these scaffolds in repairing the 
bone defects over 4 to 12 weeks. The experimental results showed that the cells demonstrated 
excellent attachment ability on the CPA scaffolds, as well as remarkable upregulation of the levels 
of osteoblastic markers such as Runx2, Osterix, collagen 1, osteopontin, and osteocalcin. 
Furthermore, results from radiography, micro-computed tomography, histological and 
immunohistochemical analysis demonstrated that abundant new bones were formed on the CPA 
scaffolds. Ultimately, these results demonstrated that CPA composite scaffolds have excellent 
capability in bone tissue engineering applications and have the potential to be used as effective bone 
regeneration and repair scaffolds in clinical applications. 
KEYWORDS: Attapulgite, Polycaprolactone, Collagen 1, Composite scaffold, Bone regeneration, 
Mouse multipotent mesenchymal precursor cell line D1   
 
1. INTRODUCTION 
Repairing bone defects caused by bone tumor resections, fracture defects, or chronic infection is still 
challenging in orthopedic practice1-3. Autograft is the gold-standard approach in current bone repair. 
However, this technique has several disadvantages, including limited supply of bone tissue, 
induction of new trauma, and the potential for functional damage4, 5. Allografts are also used clinically 
because of the availability in bone tissue supply, but these grafts carry the risk of infection, disease 
transmission, and the induction of immune response6-8. Advances in bone tissue engineering (BTE) 
have the potential to address these challenges and promote bone regeneration and repair9-12. 
However, fabricating 3D porous scaffolds for cell migration, proliferation, differentiation, and nutrient 
delivery is challenging. 
An ideal scaffold for BTE should have i) excellent mechanical properties to enable the bone tissue 
remodeling; ii) excellent biocompatibility to facilitate cell attachment and proliferation; iii) appropriate 
biodegradability with controllable degradation and resorption rates to match the bone regeneration; 
3 
  
iiii) appropriate porosity for cells to attach, migrate, proliferate and deposit extracellular matrix (ECM)1, 
13. Interconnection of pores is also required to allow the transportation of nutrients, metabolites and 
waste products removal1, 14, 15. 
In general, three types of bone scaffold materials have been explored in the past: bioactive 
ceramics, biodegradable metals and biodegradable polymers. Bioactive ceramics such as calcium 
phosphate (CaP) ceramics, including hydroxyapatite (HA) and tricalcium phosphate (TCP) have 
similar compositions to natural bone. These materials have good biocompatibility and 
osteoconductivity. The degradation of these materials releases ions that can enhance the cell activity 
and facilitate the bone repair. However, bioactive ceramics have low toughness and insufficient 
strength, therefore are not ideal to be used without the addition of other materials1. For example, HA 
is one of the major constituents of natural bone, accounting for 70% (by weight) of human bone16. 
HA material is biocompatible, osteoconductive, noncytotoxic, and nonimmunogenic and has a slow 
degradation rate17-19. Therefore, it has been widely used in BTE5, 20. However, HA is fragile, inflexible, 
and is difficult to model, limiting its application in bone regeneration and repair17, 21. Calcium 
phosphate (CaP) bioceramics have also been successfully applied in hard tissue regeneration as a 
gold standard. These bioceramics exhibit excellent biocompatibility and chemical similarity with hard 
tissues. Therefore, they have been extensively used in clinical repair of bone defects. Recently 
additive manufacturing has been employed for the fabrication of bioceramic scaffolds in addition to 
those traditional methods such as solvent casting, freeze drying, phase separation etc. However, 
due to their brittleness, poor mechanical properties and lack of other valuable trace metal ions (e.g. 
Si4+, Sr2+, and Mg2+), these materials are only limited to the defects of non-load-bearing bone. To 
improve the mechanical properties, osteoconductivity, osteogenic ability and printability of the CaP 
bioceramics, inorganic and organic materials have to be incorporated with CaP bioceramics 22. In 
contrast, biodegradable metals such as Mg, Zn, Fe, and their alloys have better toughness and 
processability than bioactive ceramics. However, biodegradable metals have a fast degradation 
process. The rapid degradation leads to the quick loss of mechanical integrity and stability1. Polymer 
materials are the most extensively used materials for BTE. So far, a considerable number of polymer 
materials such as polycaprolactone (PCL), poly-L-lactic Acid (PLLA), polyglycolic acid (PGA), 
polylactic acid (PLA) and poly (lactic-co-glycolic) acid (PLGA) have been developed for bone 
regeneration23-29 due to their wide availability, and good mechanical properties. However, synthetic 
polymers are lack of bioactivity, cell affinity, and hydrophilicity1. Therefore, the three types of bone 
materials each has its advantages and disadvantages. Composite scaffolds made from the above 
materials combine their advantages and eliminate their shortcomes providing improved properties 
for BTE. Bioactive ceramics or biodegradable metals provide osteoconductivity, mechanical strength 
and the minerals required for BTE. Polymers can be used as binders to reinforce the mechanical 
property of bioactive ceramics and biodegradable metals and help model the architecture30. For 
example, chitosan has been used to make composite scaffolds with nanohydroxyapatite. It was 
found that the compression modulus increased with the amount of nanohydroxyapatite. The 
composite scaffolds were found superior in terms of cell attachment, proliferation, and morphology 
in relation to chitosan scaffold31. PLGA and PCL have also been widely used as a binder for HA in 
the past decades with PCL based composites attracted more attention than other synthetic polymer 
composites2, 15, 31, 32. For example, composite scaffolds made from PCL and oyster shell powder 
4 
  
showed Improved crystallinity and mineralization ability for BTE application33. PCL has also been 
combined with octacalcium phosphate to fabricate electrospun scaffolds for BTE32. Enhanced 
performance of osteoblast human G-292 cells on the scaffolds was observed.  
While a number of excellent polymers are available, the numbers of excellent bioactive ceramics are 
much less. Attapulgite (ATP) is a natural clay mineral that has been used in the environmental 
industry as an adsorbent34, as a decolorizing agent35, and for catalyst support36. ATP is composed 
of SiO2 (55.03%), Al2O3 (10.24%), MgO (10.49%), Fe2O3 (3.53%), H2O+ (10.13%), and H2O− 
(9.73%)37-39, and is well known for its porosity, large specific surface area, high viscosity, and 
absorption ability. It possesses the physical properties as well as the minerals desired for BTE. 
Recently, it has been reported that electrospun ATP/PLGA nanofibers promote the differentiation of 
human mesenchymal stem cells into osteoblasts40, making ATP a promising scaffold material for 
BTE. Combining the advantages of ATP and polymers will provide a new strategy for improved bone 
regeneration38. However, the use of ATP as bone tissue-engineering for bone repair is only emerging. 
Further studies are required to optimize its applications in BTE.  
In this study, collagen (type 1)/polycaprolactone/attapulgite (COL1/PCL/ATP) composite scaffolds 
were fabricated for the BTE. Collagen is an extracellular matrix (ECM) protein of the main tissues 
(skin, blood vessels, and bone) 41, 42. Scaffold manufactured with collagen has excellent 
biocompatibility and biodegradability43. Collagen is often cross-linked by physical and chemical 
methods using ultraviolet light, glutaraldehyde, or genipin7, 44 to increase its mechanical properties. 
PCL has been widely used in regenerative medicine because of its good biocompatibility, elasticity 
and low immunogenic response2, 18. The purpose of this study was to compare a COL1/PCL/ATP 
(CPA) scaffold with a COL1/PCL (CP) scaffold to find out whether the addition of ATP can improve 
the differentiation of bone marrow–derived stroma cells into osteoblast cells, thus promoting bone 
regeneration. The scaffolds were made through salt leaching method as illustrated in the ToC figure 
and were characterized by a combination of SEM, FTIR and mechanism tests. The elemental 
composition, porosity, water absorption, contact angle, and degradation were investigated. Cell 
proliferation and morphology on the scaffolds, as well as the expression of bone regeneration related 
proteins such as Runx2, Osterix, alkaline phosphatase (ALP), collagen 1 (COL1), osteocalcin (OC), 
and osteopontin (OPN) were studied. The scaffolds were implanted into bone defects using rabbit 
model. Radiography, micro-CT Scan, histological and immunohistochemical staining were used to 
evaluate the in vivo bone regeneration. The current study demonstrated that CPA composite 
scaffolds have great potential in BTE applications.    
 
2. MATERIALS AND METHODS 
2.1 Preparation of CP and CPA Scaffolds 
The porous cylindrical CP and CPA scaffolds were fabricated using a salt-leaching method45. Briefly, 
collagen type 1 (COL1) was dissolved in hexafluoro-isopropanol (HFLP) to obtain an 8% (w/v) 
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uniform solution. PCL polymer powder (Sigma-Aldrich, USA) was then added to the solution with 
magnetic stirring until a homogeneous solution was formed. The ratio of COL1: PCL was 4:1 (w/w). 
Various volumes of nanosized ATP (150-500 nm, Lanzhou Institute of Chemical Physics, Chinese 
Academy of Sciences) power and sodium chloride particles (250-500 たm, Shanghai Chemical 
Industry, China) were mixed with the solution to form pastes with ATP concentrations of 0% (CP 
scaffold; COL1:PCL:ATP mass ratio of 40:40:0), 10% (CPA-low dose [CPA-L] scaffold; 
COL1:PCL:ATP mass ratio of 40:40:10), and 20% (CPA-high dose [CPA-H] scaffold; COL1:PCL:ATP 
mass ratio of 40:40:20). The pastes were then placed into molds that were 100 mm in length and 10 
mm in diameter. The molds were left in the drying oven for 6 - 8 h, and the HFLP was completely 
evaporated in a vacuum condition until circular cylinders had formed. The resulting highly porous CP 
and CPA scaffolds had lengths of 45 to 50 mm and diameter of 4 mm. The scaffolds were then placed 
into deionized (DI) water for 72 h to elute all the sodium chloride. Samples were then tested with 
0.1 % AgNO3 to conform the complete removal of NaCl.  
EDC/NHS (in ethanol: water at 80:20 v/v) were used to crosslink the CP and CPA scaffolds. The air-
dried scaffolds were placed in 250 mM EDC/NHS solution for 24 h at room temperature before rinsing 
3 times with DI water to remove the residual EDC/NHS. After which the scaffolds were dried at room 
temperature. Each scaffold was cut with a surgical knife blade to 4 mm in diameter and 15 mm in 
length, sealed, and sterilized with Co60. 
2.2 Scanning Electron Microscopy 
Attapulgite (ATP): The morphology and mineral content of the ATP were investigated using the 
scanning electron microscopy (SEM, Hitachi S-3400N system, Japan). ATP was deposited onto a 
carbon-coated copper grid and coated with gold for 1 h before observation. Six samples were tested 
with 3 times for each sample.  
CP and CPA Scaffolds: SEM (JHitachi S 3400N, Japan) was used to observe the interconnected 
porous structure and composition of the scaffolds. Before observation, scaffolds stored in 100% 
ethanol were dried by supercritical carbon dioxide. 
2.3 Water Absorption, Porosity, Contact Angles, and Degradation of Scaffolds 
The water absorption capacities of the CP and CPA scaffolds were determined by swelling the 
scaffolds in 0.2 M PBS at 37°C ( pH = 7.4). The scaffolds were cut into 10 mm in length and 4 mm in 
diameter, and separately immersed into 0.2 M PBS solution for 5 min and then for 1, 2, 3, 4, 5, 6, 
24, 48, and 72 h. The water in each scaffold was then removed and weighed. The water absorption 
ratio was obtained with the following equation:  




where WH is the weight of the soaked scaffold and WD is the weight of the dry scaffold.  
For assessment of scaffold porosity, cylindrical samples were cut into 2 mm in length and 4 mm in 
diameter pieces. The porosity of the scaffolds was measured based on gravimetry according to the 
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following equation:  
Porosity (%) = 
ெమିெయିெೄெభିெయ ൈ ͳͲͲΨ 
where M1 is the initial mass of a density bottle filled with ethanol, Ms is the mass of the dry scaffold, 
M2 is the mass of the scaffold submerged in absolute ethanol with the density bottle, and M3 is the 
mass of the density bottle after the scaffold was gently removed.  
The contact angle measurement of the scaffolds was carried out with a contact angle analyzer 
(FTA125, First Ten Angstroms, Portsmouth, VA, USA). The scaffolds were cut into 1 cm2 square 
pieces (N = 4) and then placed on a testing plate. Subsequently, 0.01 mL of DI water was carefully 
dropped onto the test sample surface. After 10 seconds, the contact angles were recorded by video 
monitor.  
For assessment of scaffold degradation, cylindrical samples were cut into 10 mm lengths. The 
samples were placed into vials containing 5 mL PBS (pH = 7.4, 0.2 M), and these vials were placed 
into a shaking bath (37°C) for 1 to 8 weeks. The PBS solution was exchanged weekly. The loss in 
mass of the scaffolds was then calculated using the following equation: 
Weight lost (%) = ெబିெವெబ ൈ ͳͲͲΨ 
where M0 is the initial dry weight of the scaffold and MD is the dry weight after degradation. 
2.4 Fourier transform infrared spectroscopy (FTIR) 
Fourier transform infrared spectroscopy (Perkin-Elmer 1600 series, USA) was used to evaluate the 
functional groups of the scaffolds. Before testing, a total of 2 mg dried CP or CPA scaffold powder 
was mixed with 200 mg KBr and compressed into a disk. All spectra were obtained between 4000 
and 400 cm-1 at a 4 cm-1 resolution with 32 scans. Six samples were examined for 3 times each. 
2.5 Mechanical Testing 
Before testing, the scaffolds were cut so that the gauge length and diameter of all specimens were 
8 mm and 4 mm, respectively. For assessment of flexural strength, the scaffolds were tested with a 
3-point bend test on an Instron 4505 universal testing machine (Instron Pty Ltd., Norwood, MA, USA) 
at a rate of 1 mm/min. Compressive tests were performed on dry and wet scaffold (After immersion 
in the 0.02 M PBS (pH=7.4) for 3 days) samples using a universal testing machine with a 1 kN load 
cell. Specimens were compressed to 60% of their total height at a rate of 2 mm/min to obtain the 
load/displacement curve. Stress-strain graphs were then drawn according to the load/deformation 
data.  
2.6 Cell Culture and Seeding on Scaffolds  
Cells from the D1 mouse multipotent mesenchymal precursor cell line (CRL-12424, ATCC, USA) 
were cultured in DMEM/F12 (Gibco, USA) supplemented with 10% fetal calf serum (FCS) and 1% 
penicillin/streptomycin at 37°C and 5% CO2. The scaffolds were sterilized with 70% ethanol for 1 h 
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and then rinsed 3 times with sterile PBS before the cells were loaded. The scaffolds were soaked in 
the DMEM/F12 medium overnight. Cells (15 µL, approximately 1.6 × 105 cells/mL) were seeded on 
both sides of the scaffold with a 2 h incubation step between additional seedings. The cell-seeded 
scaffolds were then placed into new 24-well plates containing 1 mL of DMEM/F12 complete medium. 
The plates were incubated at 37°C  with 5% CO2 and were cultured for 7 to 21 days. During this 
period, the medium was changed twice weekly. At the desired time points, the cell-seeded scaffolds 
were removed from the medium and analyzed for cell adhesion, proliferation, and expression of 
osteoblast-related genes. 
2.7 Cell Proliferation and Morphology 
Cell proliferation was measured using the Cell Counting Kit-8 (CCK-8; Promega, USA). In brief, the 
cell- seeded scaffold was removed from the original medium and placed into new cell culture plates 
after 1 to 7 days of culture. A total of 1 mL of medium containing 100 µL CCK-8 was added into each 
well, and the plates were incubated at 37°C for 3 h. A total of 200 µL supernatant was then removed 
from each well to a new 96-well plate and tested for absorbance at 490 nm using a plate reader 
(BIOTEK, USA). Six parallel samples from each group were analyzed, and each test was run in 
triplicate. DMEM/F12 containing 100 µL CCK-8 was used as a control.  
The microstructures of the scaffolds and the cell-seeded scaffolds were assessed using SEM (JSM-
5800LV). At day 3 and 7, the cell-seeded scaffolds were fixed in 2.5% glutaraldehyde in PBS for 3 
additional days. The samples were then dehydrated through a series of alcohol with different 
concentrations (15%, 30%, 50%, 70%, 80%, 90%, 100%) followed by drying with supercritical carbon 
dioxide. Samples were sputter coated with gold for 10 min before the SEM measurement. Cell 
morphology, attachment on scaffolds, and cell density were assessed, respectively. 
2.8 Fluorescence Staining 
At day 7, the cell-seeded scaffolds were rinsed in 0. 2 M PBS and fixed in 10% formaldehyde for 3 
additional days. After dehydration, the scaffolds were embedded in paraffin, and 5 µm sections were 
used for fluorescence staining. Samples were stained with 3 µM 4',6-diamidino-2-phenylindole 
dihydrochloride (DAPI, Sigma, USA) for the nucleus and 10 µM phalloidin (Invitrogen Life 
Technologies, USA) for the F-actin filaments. The samples were then observed under a fluorescence 
microscope (Olympus, Japan).  
2.9 Reverse Transcriptase and Quantitative Real-Time PCR 
The total RNA of the cells was extracted using the Trizol reagent (Invitrogen, USA) following the 
manufacturer’s procedure. Samples with 2 µg total RNA were reverse transcribed using the M-MLV 
Reverse Transcription kit with an oligo (dT) 18 primer (TaKaRa Company, Dalian, China). PCR 
amplification was carried out in a volume of 25 µL, which contained 200 ng cDNA, 20 µM each of 
the forward and reverse primers (Glyceraldehyde phosphate dehydrogenase [GAPDH], Runx2, 
Osterix, alkaline phosphatase [ALP], COL1, osteocalcin [OC], and osteopontin [OPN]), which were 
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designed using Primer 3 software, and 12.5 µL of the Power SYBR Green PCR Master Mix (TaKaRa). 
The real-time PCR cycling conditions comprised an initial denaturation step at 95°C for 10 min, 30 
cycles of 30 seconds at 95°C for denaturation, 30 seconds at 60°C for annealing, 60 seconds at 
72°C for extension, and 10 min at 72°C for a final extension. Relative gene expression was detected 
using a comparative Ct method (2−ddCt) using the following equation46: 
Relative gene expression = 2−ddCt (DCt sample - DCt control) 
Assays were carried out in triplicate for each gene. 
2.10 Examination of Bone Regeneration in Rabbits 
To assess the ability of the CPA-H and CP scaffolds to promote bone regeneration in a critical-sized 
defect, 15 mm rabbit radius defect model was used. male Japanese white rabbits (60 in total; 2 
months old; weight: 1.5-2.0 kg) were used in the study and were divided into three groups: defect 
control, CP, and CPA-H. All animals were anesthetized by intravenous injection of pentobarbital 
sodium (0.3 mL/kg). The both radius bone was exposed with a straight incision approximately 3 cm 
in length along the forearm bone, and 15 mm defects were made in the bilateral radius using an 
electric drill. Bone debris was removed with physiologic saline irrigation. The radius defects were 
then implanted with CP or CPA-H scaffolds (CP and CPA-H groups), with the scaffolds fixed to the 
ulna using absorbable sutures. In the control group, no scaffolds were implanted in the defects. The 
wounds were then sutured. To prevent postoperative infections, penicillin injections (400k units) were 
administered once a day for 7 days. The general conditions of the rabbits (diet, activity, energy, and 
wound healing) were continuously monitored for 2 weeks. The following experiments were carried 
out at 4, 8, and 12 weeks after surgery, respectively. 
2.11 Radiological Monitoring 
Radiography was performed to identify new bone regeneration during the healing process. Images 
were captured at 4, 8, and 12 weeks after surgery using X-ray machine (Faxitron MX-20, USA). 
Images were obtained at 45 Kv and at 3 to 5 mAs. Evidence of callus formation and bone healing in 
the area of defects was also assessed.  
2.12 Micro-CT Scan 
After radiographic examination, the rabbits were euthanized with an overdose of pentobarbital. The 
soft tissues attached to the bone defects were removed and the tibias were harvested and fixed in 
10% formaldehyde for 48 h. The tibias were scanned using Micro-computed tomography (micro-CT) 
(GE Healthcare, USA) with the following parameters: voxel resolution of 15鳥µm with an integration 
time of 300鳥ms, at 50鳥keV with 850鳥µA current. Micro-CT software was used to transformed into 3D 
images and measure the bone mineral density of new bones. 3 rabbits in each group were chose to 
scan at 4, 8, and 12 weeks after surgery, each sample was scanned 3 times, and the amount of 
bone regeneration was calculated based on the average value. 
2.13 Histological and Immunohistochemical Staining 
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Tibias were fixed in 10% formaldehyde for 3 days and were then decalcified in 5% EDTA at room 
temperature (pH = 7.0) for 5 weeks. After complete decalcification, the bone specimens were 
dehydrated in ascending ethanol and then embedded in paraffin. The paraffin blocks were sectioned 
into 5 µm thicknesses, stained with H&E and Masson staining, and analyzed with a microscope 
(Olympus, Japan). The quantity of new bone area ratio was assessed using Image-Pro Plus 6.0 
software (Media Cybernetics, Rockville, MD, USA). For immunohistochemical analysis, the sections 
were deparaffinized and then rehydrated by boiling them for 10 min in a sodium citrate solution. The 
following protocols were performed according to the manual of the immunohistochemical kit: 
Sections were treated with several primary antibodies: rabbit monoclonal ALP antibody (1:1000, 
overnight at 4°C; Abcam, USA), rabbit monoclonal COL1 (1:1000, overnight at 4°C; Abcam, USA), 
rabbit monoclonal type 2 collagen (COL2) (1:1000, overnight at 4°C; Abcam, USA), (1:1000, 
overnight at 4°C; Abcam, USA), and rabbit monoclonal OPN antibody (1:1000, overnight at 4°C; 
Abcam, USA); and then with a biotinylated goat anti-mouse or anti-rabbit secondary antibody for 30 
minutes. Sections were stained with 3,3’-diaminobenzidine tetrahydrochloride (DAB; Sigma, USA), 
rinsed with PBS, dehydrated, and examined with a microscope (Olympus). All histological and 
immunohistochemical images were photographed digitally with a microscope and analyzed with a 
digital image analysis system (DXM 1200, Nikon, Japan).  
2.14 Study Approval 
All animal experiments in this study were approved by China’s Animal Research Authority and Ethics 
Committee of the General Hospital of Lanzhou Military Command of the PLA. All animal studies were 
performed in compliance with the regulations and guidelines of the Orthopedics department of the 
General Hospital of Lanzhou Military Command of the PLA, and animal care was conducted 
according to the Association for Assessment and Accreditation of Laboratory Animal Care 
international (AAALAC) and Institutional Animal Care and Use Committee (IACUC) guidelines. 
2.15 Statistical Analyses 
All data are presented as means ± standard deviations. A two-tailed unpaired Student’s t test was 
used to assess for significant differences between groups; P value < 0.05 was considered statistically 
significant. SPSS 13.0 statistical software (SPSS, USA) was used to analyze all data.  
 
3. RESULTS 
3.1 Morphology and Chemical Composition of the ATP and CPA Scaffolds 
SEM measurements were carried out to reveal the morphology of the ATP, COL1/PCL (CP) and 
COL1/PCL/ATP (CPA) scaffolds with the data shown in Figure 1. ATP (Figure 1A) showed clusters 
of single rod structure with relatively smooth surfaces. The approximate length of the ATP rods was 
0.2 to 1.8 µm with the diameter range from 15 to 50 nm. ATP was found composed of SiO2 (33.7%), 
MgO (9.0%), Al2O3 (5.6%), Fe2O3 (4.1%), CaO (1.5%), KBr (1.3%), and Ti (0.5%) (Figure 1Ac). 
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Figure1B shows the SEM micrographs of CP and CPA scaffolds. The scaffolds showed porous 
structures, with pore sizes ranging from 250 to 500 たm, which were created by the sodium chloride 
particles. This porosity was beneficial for nutrient exchange and cell migration. Figure 1C shows the 
chemical composition of the CPA-H scaffolds. Strong signals were detected for Si, Mg, Al, and Fe, 
indicating the presence of ATP in the scaffolds. With an increase in ATP, Si was also increased 
(Figure S1), indicating the existence of an Si-containing material in the scaffolds. A strong carbon 
signal was also detected in the CPA scaffolds. 
 
Figure 1. (A) Surface topography of attapulgite (ATP) (a & b) with the elemental composition of ATP 
shown in (c). (B) SEM micrographs of the surface topography of CP, CPA-low dose (CPA-L), and 
CPA high-dose (CPA-H) scaffolds. (C) Distribution of the elemental composition of the CPA–H 
scaffold. 
3.2 Characterization of the scaffolds: Porosity, water absorption, contact angle, degradability, 
mechanical properties, and FTIR study  
The CPA-H scaffold with and without cross-linking were observed under SEM. Higher porosity was 
observed in CPA scaffolds that were not cross-linked (Figure 2A). When the scaffold was cross-
linked by EDC/NHS, the structure became more compacted (Figure 2B) with decreased porosity. 
However, after cross-linking, the porosity values for CP (87.7%), CPA-L (82.9%) and CPA-H (82.9%) 
were very similar (Figure 2C). The addition of the ATP only resulted in small decrease of the porosity. 
The water absorption values for the cross-linked scaffolds are shown in Figure 2D. The water 
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absorption values decreased from 281.7% for CP to 234.9% for CPA-L and 150.7% for CPA-H, 
indicating that the water absorption capacity of the scaffolds decreased with increasing ATP 
concentration. The was due to the fact that ATP has less water adsorption ability. The contact angles 
(shown in Figure 2E) of the scaffolds were 76° for CP, 57.3° for CPA-L and 42.5° for CPA-H. These 
data suggest that the contact angle of the scaffolds was decreased when the amount of ATP was 
increased. Figure 3F shows the degradability of the cross-linked scaffolds after immersion in PBS 
solution. After being soaked for 8 weeks, the CPA-H, CPA-L, and CP scaffolds demonstrated weight 
loss values of 42.6%, 47.1%, and 70.2%, respectively, suggesting that the degradability of the 
scaffolds was decreased when the amount of ATP was increased. 
 
Figure 2. Characterization of the CP and CPA scaffolds. (A & B) SEM micrographs of CPA-H 
scaffolds with (B) and without (A) cross-linking. (C) Porosity, (D) water absorption, (E) contact angle, 
and (F) degradability of the CP and CPA scaffolds. (G-K) Mechanical properties of the CP and CPA 
scaffolds. (G & I) Stress/strain curves from the 3-point bend test of the CP and CPA scaffolds. (H & 
J) Stress/strain curves from the compression test of the CP and CPA scaffolds. (K) Stress/strain 
curves from the compression test of the CP and CPA scaffolds on wet condition. (L) FTIR spectra of 
the CP, CPA-L and CPA-H scaffolds. Data are shown as mean ± standard deviation (n = 4). * P < 
0.05; ** P < 0.01.  
The stress-strain curves from the 3-point bend test are shown in Figure 2G and 2I. The average 
tensile strengths of the uncross-linked CPA scaffolds were 20.0 ± 1.0 MPa for CPA-H and 15.04 ± 
0.7 MPa for CPA-L, higher than the tensile strength of the uncross-linked CP scaffolds (8.2 ± 0.3 
MPa) (Figure 2G). Meanwhile, the average tensile strength of the cross-linked CPA-H scaffolds was 
32.6 ± 2.2 MPa, higher than the tensile strengths of the cross-linked CPA-L scaffolds (21.4 ± 1.8 
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MPa) and the cross-linked CP scaffolds (16.2 ± 1.4 MPa) (Figure 2I). These data demonstrated that 
both addition of ATP and cross-linking of the scaffolds increased the tensile strength of the scaffolds. 
Figure 2H and 2J show the compressive strength of the scaffolds. The average compressive strength 
of the uncross-linked CPA scaffolds was 109 ± 6 MPa for CPA-H and 72.5 ± 0.6 MPa for CPA-L, 
higher than the compressive strength of the uncross-linked CP scaffolds (65.4 ± 2.1 MPa). The 
average compressive strength of the cross-linked CPA-H scaffolds was 261 ± 4 MPa, higher than 
the compressive strengths of the cross-linked CPA-L scaffolds (192 ± 4 MPa) and the cross-linked 
CP scaffolds (125 ± 5 MPa). On the wet condition, the average compressive strength of the cross-
linked CPA-H scaffolds was 90.3 ± 4 MPa, higher than the compressive strengths of the cross-linked 
CPA-L scaffolds (79.5 ± 1 MPa) and the cross-linked CP scaffolds (59.65 ± 2 MPa).These results 
demonstrated that both addition of ATP and cross-linking of the scaffolds increased the compressive 
strength of the scaffolds. 
The FTIR spectra of the scaffolds are shown in Figure 2L. The spectra of the CPA scaffolds 
demonstrated a typical and predominantly antisymmetrical stretching vibration peak at 1100 cm-1, 
representing the Si-O-Si bond of the CPA scaffolds. A symmetrical stretching vibration representing 
the Si-O vibrational peak at 800 cm-1 was also observed. Peaks that occurred at 3400 cm-1 and 1600 
cm-1 represented amide A and amide I from collagen in both the CP and CPA scaffolds. In the CPA 
scaffolds, amide I and amide II appeared as peaks at 1735 cm-1 and 1456 cm-1 representing C=O 
and N-H stretching of the collagen polyether peaks, respectively.  
 
3.3 Cell Morphology, Adhesion, and Proliferation on the Scaffolds 
Figure 3 shows the (CRL-12424) cell morphology, adhesion, and proliferation on the scaffolds. After 
3 days of culturing, a small number of cells was observed on the CP scaffolds, whereas large 
numbers of cells were observed on the CPA-L and CPA-H scaffolds. At day 7, the cell population 
density increased for all the scaffolds, and the deposition of extracellular matrix (ECM) was observed 
on the both CPA-L and CPA-H scaffolds. During the same time period, a very high cell density was 
observed on the CPA-H scaffold surface. The cells were more elongated on CPA-H scaffold surface. 
The pores on the scaffold were covered by the cells and ECM secreted from the cells. In addition, a 
crystal-like ECM structure was observed on the lower-right side of the CPA-H scaffolds (Figure 3A). 
Immunofluorescence staining (Figure 3B) indicated substantially higher cell numbers on the CPA 
scaffolds than that on the CP scaffolds at 7 days after inoculation.  
CCK-8 assay was performed to evaluate the cell proliferation of CRL-10915 cells on scaffolds with 
the data shown in Figure 3C. No significant difference in cell proliferation was seen for the CPA and 
CP scaffolds at day 1. At day 3, clear differences were observed. Cell proliferation increased with 
the increasing amount of ATP in the scaffolds. By day 7, cell proliferation on the CPA-H scaffolds 




Figure 3. Adhesion, proliferation and Osteogenic differentiation of D1 cells on the CP and CPA 
scaffolds. (A) SEM images of cell adhesion and proliferation at 3 and 7 days on the scaffolds. (B) 
Immunofluorescence staining of cell adhesion and proliferation on the scaffolds at day 7. Red = 
scaffold; blue = nucleus; green = F-actin. (C) Cell proliferation on the scaffolds assessed by Cell 
Counting Kit-8 assay. (D-I) mRNA expression assays of bone tissue-specific markers: (D) Runx2, 
(E) Osterix, (F) alkaline phosphatase (ALP), (G) collagen type 1 (COL1), (H) osteocalcin (OC), and 
(I) osteopontin (OPN). Data are shown as mean ± standard deviation (n = 3). Red arrow= cells; Blue 
arrow= extracellular matrix (ECM). Scale bars = 100 µm. * P < 0.05; ** P < 0.01; # P < 0.05; ƷP<0.05. 
3.4 Expression of Osteoblast Molecular Markers  
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Osteoblast molecular markers are important indicators for bone regeneration. Figure 3D-I show the 
mRNA expression of bone tissue-specific markers between 7-21 days. After 7 days of incubation, 
the expression level of Runx2 mRNA was notably increased in cells implanted on the CPA scaffolds 
versus those implanted on the CP scaffolds. The expression level of Runx2 rapidly decreased after 
14 and 21 days in cells on the CPA scaffold (Figure 3D) indicating the differentiation of the 
multipotent mesenchymal precursor cells into osteoblasts. The mRNA expression level of Osterix 
(Figure 3E) of CPA-L and CPA-H scaffolds were lower than that of CP scaffolds at day 7. However, 
it gradually increased with time and the concentration of ATP. At day 21, the mRNA expression level 
of Osterix was significantly higher than that of CP and CPA-L scaffolds. Similar trends were observed 
for the mRNA expression levels of COL1 (Figure 3G), OPN (Figure 3H) and OC (Figure 3I). For the 
mRNA expression level of ALP, the expression level was low for CP scaffold, but significantly 
increased with time and the increased percentage of ATP (Figure 3F). 
 
3.5 Implantation Procedure, Radiographic Examination and Micro-CT Scan 
The CP and CPA-H scaffolds were implanted into 15 mm rabbit radius defect model with the 
implantation procedure shown in Figure 4A. X-ray experiments were performed at 4, 8, 12 weeks 
after implantation (Figure 4B). Postoperative radiographs demonstrated that clear defects can be 
observed at the implants’ areas at week 4. However, some low-density developments were also 
observed in the bone defect areas. The bone regeneration of CPA-H is better than CPA-L and CP. 
At week 8, defects can still be seen in CP scaffold areas, while in CPA scaffold areas, the defects 
were filled in with low density new bone. At week 12, all the defects were filled in with CPA scaffolds 
have higher density bone. In the CPA-H group, a bone marrow cavity formed in the newly formed 
bone by week 12 (Figure 4B). 
Figure 4C shows the Micro-CT scan results of the scaffold areas. At 4 weeks, a small amount of 
bone-like tissue was observed within the bone defect area in the CP scaffold group (Figure 4C). 
However, the tissue mineral content was markedly lower in this group than that in the CPA-H scaffold 
group (Figure 4D). After 8 weeks, bone-like tissue was observed in the CPA-H and CP groups, but 
the bone observed in the CP group was discontinuous. In addition, the tissue mineral content of the 
bone defect area was markedly lower in the CP group than that in the CPA-H group. A large amount 
of new bone-like tissue was observed in the bone defect area of the CPA-H scaffold group at 12 
weeks after transplantation. The tissue mineral content was remarkably increased in the CPA-H 
scaffold versus the control group. The tissue mineral content showed a dose and time dependent 
manner (Figure 4D). The more ATP presented in the scaffolds the higher tissue mineral content was 




Figure 4. Implantation procedure, X-ray and micro-CT analysis of new bone. (A) Photographs 
showing the surgical implantation procedure for CP and CPA-H scaffolds in rabbit bone. 
Representative radiographs (B) and Micro-CT images (C) showing the level of regenerated bone 
tissue after 4-12 weeks. (D) Tissue mineral content of the regenerated bone tissue after 4-12 weeks. 
Data are shown as mean ± standard deviation (n = 3). CPA-H = CPA high-dose. * P < 0.05; ** P < 
0.01; # P < 0.05; ## P < 0.01.  
 
3.6 New Bone Formation Assessed by Histologic Analysis 
Histologic Analysis was performed at week 4, 8, and 12 to evaluate the new bone formation with 
data shown in Figure 5. Four weeks after transplantation, monocytes, plasma cells, and lymphocytes 
were observed within all implant scaffolds. At week 8, the presence of fibrous connective tissue was 
seen in the control group. In the CP group, the scaffold materials partially disappeared, and more 
fibrous connective tissue grew into the scaffolds, indicating the degradation of the scaffolds was 
faster than the desired degradation rate. In contrast, new bone was observed in the CPA-H scaffold 
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group. At week 12, most of the area of bone defect was covered by fibrous connective tissue in the 
control group, indicating that new bone had not been formed. In the CP group, the scaffold was 
completely replaced by fibrous tissue. In contrast, in the CPA-H group, new bone formation was 
observed around the scaffold area. The original shape of the implant scaffolds had gradually 
disappeared and was visible only in the center of the scaffolds (Figures 5A and 5C). 
 
Figure 5. Histological staining of the newly formed bone 4-12 weeks after implantation of CP and 
CPA-H scaffolds in rabbit bone defects. (A) Hematoxylin and eosin (H&E) staining. (B) Masson 
staining. (C & D) show the quantitative data from (A & B), respectively. Scale bar = 100 µm. F = 
fibrous tissue; HB = host bone; IM = implanted material; NB = new bone. * P < 0.05, ** P < 0.01, *** 
P < 0.01, # P < 0.05, ## P < 0.01. 
Masson staining (Figure 5B) demonstrated that the control group had fibrous tissue at the bone 
defect area 4 weeks after transplantation. The fibrous tissue filled in the central portion of the defect 
area. On the other hand, the reconnected fibrous tissue and small areas of bone-like tissue had been 
found in the defect bone in the CP and CPA-H scaffold groups. In the CPA-H group, single bone 
fragments were observed 8 weeks after scaffold implantation. At 12 weeks, abundant new bone 
formation was seen in the center of the CPA-H scaffolds, but CPA-H materials had not been 






Figure 6. Immunohistochemical staining of the newly formed bone 4-12 weeks after implantation of 
CP and CPA-H scaffolds in rabbit bone defects. (A, C, E and G) Immunohistochemical staining for 
(A) alkaline phosphatase (ALP), (C) type 1 collagen (COL1), (E) type 2 collagen (COL2), and (G) 
osteopontin (OPN). (B, D, F, and H) shown the quantitative data from (A, C, E and G), respectively. 
Data are shown as mean ± standard deviation (n = 6). Scale bar = 100 µm. * P < 0.05, ** P < 0.01, 
*** P < 0.01, # P < 0.05, ## P < 0.01. 
 
3.7 Immunohistochemical Assessment 
The data of immunohistochemical assessment are shown in Figure 6. Four weeks after implantation, 
positive expression of ALP, COL1, COL2, and OPN was observed in all three groups. For ALP, 
COL2 and OPN, the expression levels showed the time and ATP dose dependent effects for all three 
groups, while the expression levels in CPA-H scaffolds were higher than that in CP scaffolds and 
control group. For COL1, high expression was observed in control group. The level of expression 
was found similar between 4-12 weeks. In CP group, COL1 expression increased with time, while in 
CPA-H group, COL1 expression increased with time and leveled off at week 12. The high expression 
of COL1 in control demonstrated the presence of cartilage tissue within the control group, indicating 
that the bone regeneration was not good. The intensity of positive staining for ALP, COL1 COL2 and 
OPN in the CPA-H scaffolds increased over time. This expression was mainly seen in the border of 
the new bone. The results demonstrate that in the control group the new tissue formed was mainly 
fibrous tissue containing a lot of collagen type 1. While in the CP and CPA-H groups, new bone 
tissues were formed and the amount of new bone in CPA-H group was much higher than that in CP 
group.   
 
4. DISCUSSION 
In this work, we investigated the bone regeneration efficacy of the CPA composite scaffolds for 
segmental bone defect healing. Our results show that the water absorption, porosity, contact angle, 
and degradation of the scaffolds were improved with increasing ATP content. Pore sizes are 
important for BTE scaffolds and has been shown to affect the progression of osteogenesis47. Small 
pore sizes (< 100 µm) not only reduce cell migration but also restrict nutrient delivery and waste 
removal. Additionally, it also limit the amount of new tissue regeneration47. It has been reported that 
pore sizes > 100 µm with gradients are recommended2, 48. In our study, the CP and CPA composite 
scaffolds were fabricated by salt-leaching method. The scaffolds showed porous structures, with 
pore sizes ranging from 250 to 500 たm, which were created by the sodium chloride particles. This 
porosity was beneficial for nutrient exchange, cell migration, and bone regeneration. 
Ideally, biomaterials implants for clinical applications should match the mechanical properties of the 
host tissue and exhibit strong interfacial bonds with hard and/or soft tissues. However, the major 
disadvantages of the inorganic and organic component are their low mechanical strength and 
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fracture toughness, which typically restrict their use bone tissue engineering3. Our results showed 
that higher concentration of ATP also led to increased compressive strength, suggesting that 
increased ATP leads to improved mechanical strength. The ATP can provide both strength and 
bioactivity, while the collagen can add structural reinforcement, and toughness. The mechanical 
strength of the CPA composite scaffolds is lower than that of the natural bone. In the future, our 
strategies are to produce enhanced composites and use novel fabrication methods (e.g. 3D printing) 
to overcome this drawback. 
Cytocompatibility of the biomaterials used in scaffolds plays a vital role in sustaining cell adhesion, 
proliferation, and differentiation and in enabling tissue regeneration after implantation49. In this study, 
the CPA scaffolds promoted colony morphology and induced cell proliferation when they were 
cocultured with cells for 1 to 7 days. The proliferation rate of cells on the CPA-H scaffold was 
significantly higher than the rate on the CPA-L and CP scaffolds after 7 days, suggesting that CPA 
scaffolds induce the proliferation of cells in a dose-dependent manner and the addition of ATP has 
significant effect to the cell growth. These results are consistent to the results reported by Wang et 
al.40, who found that the doping of ATP within the PLGA nanofibers is able to induce the osteoblastic 
differentiation of hMSCs. Our results also demonstrate that CPA scaffold can increase the cell 
proliferation and promote osteoblasts related gene expression, therefore increase bone regeneration.   
An immunofluorescence assay demonstrated that D1 cells was able to proliferate and migrate in the 
interior of the CPA scaffolds. Additionally, in vivo studies in a rat model demonstrated no evidence 
of severe immune response or fibrous capsule formation with the CPA scaffolds, suggesting good 
biocompatibility. The D1 cells grown on CPA scaffolds had upregulated levels of osteoblastic 
markers, including upregulated levels of Runx2 at day 7 and Osterix at day 21. These results suggest 
that D1 cells can differentiate into osteoblasts on CPA scaffolds. We also found that the expressions 
of COL1, ALP, OC, and OPN were significantly higher on CPA scaffolds than that on CP scaffolds, 
and this increased expression occurred in a dose-dependent and time-dependent manner. These in 
vitro findings suggest that CPA has strong osteoinductive properties. CPA may promote D1 cell 
osteoblast differentiation through several mechanisms: i), The elements from ATP (SiO2, Al2O3, MgO, 
Fe2O3, H2O+, and H2O−), especially SiO2, can induce D1 cells to differentiate into osteoblasts1. ii), 
ATP has desired physical properties, such as larger specific surface area, high viscosity, and high 
absorption ability, that make this mineral osteoinductive. iii), the synergistic effect between the 
chemical and physical properties of ATP may induce D1 cells to differentiate into osteoblasts.  
During the in vivo bone tissues formation, the biomaterial should degrade slowly to match the perfect 
restoration of the bone defect39, 50. In the rabbit model we used in this study, a large amount of bone 
mass was observed in the CPA scaffold groups at weeks 8 and 12. This was especially obvious in 
the scaffold that contained CPA-H, in which the bone mass completely filled in the bony defect at 
week 12. Immunohistochemical analysis also demonstrated remarkable increase in the expression 
of ALP, COL1, COL2, and OPN in the CPA scaffolds versus in the CP scaffolds at weeks 8 and 12. 
These findings again suggest that ATP was able to induce the formation of vital bony structures. 
While the ATP has not yet been widely used in tissue engineering, this study opens a door for ATP 
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as a promising material for tissue engineering applications.   
 
5.  CONCLUSIONS 
Salt leaching is an effective method of scaffold fabrication that has been used to create the 
macroporous scaffolds needed for bone tissue engineering51. In this study, we used the salt-leaching 
method to fabricate macro-mesoporous scaffolds containing either COL1/PCL or COL1/PCL/ATP as 
bone regeneration materials. We found that macropores (approximately 200-500 たm) had been 
created by sodium chloride in both the CP and CPA scaffolds, which is important for cell ingrowth 
and nutrition delivery. Cross-linking of the collagen with EDC/NHS changed the structure of the 
collagen, which led to changes in porosity and water absorption. Cross-linking improved the 
compressive strength and decreased the porosity of the CPA scaffolds. These results suggest that 
a cross-linked CPA scaffolds are more suitable for BTE. In conclusion, we found that CPA scaffolds 
prepared through a salt-leaching technique were more effective than CP scaffolds in inducing bone 
regeneration. These results suggest that CPA scaffolds, because of their specific physical and 
chemical properties, may have great potential for the induction of bone regeneration and promotion 
of bone repair. Further studies are needed to assess the use of these scaffolds in a clinical setting. 
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;ﾐS ﾐ;ﾐﾗゲI;ﾉW デWIｴﾐﾗﾉﾗｪｷWゲ aﾗヴ デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪ ;ﾐS Sヴ┌ｪ SWﾉｷ┗Wヴ┞ ;ヮヮﾉｷI;デｷﾗﾐゲく Jﾗ┌ヴﾐ;ﾉ ﾗa Tｷゲゲ┌W EﾐｪｷﾐWWヴｷﾐｪ ;ﾐS 
RWｪWﾐWヴ;デｷ┗W MWSｷIｷﾐW ϮϬϭϰ͕ Β ふヱぶが ヱどヱヴく 
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Βく Cｴｷ;が Hく Nくき W┌が Bく Mくが RWIWﾐデ ;S┗;ﾐIWゲ ｷﾐ ンD ヮヴｷﾐデｷﾐｪ ﾗa Hｷﾗﾏ;デWヴｷ;ﾉゲく J Bｷﾗﾉ Eﾐｪ ϮϬϭϱ͕ Γが ヴく 
Γく J;ﾆﾗHゲゲﾗﾐが Aくき  Oデデﾗゲゲﾗﾐが Mくき  );ﾉｷゲが Mく Cくき  OろC;ヴヴﾗﾉﾉが Dくき  Jﾗｴ;ﾐゲゲﾗﾐが Uく Eくき Jﾗｴ;ﾐゲゲﾗﾐが Fくが TｴヴWWどSｷﾏWﾐゲｷﾗﾐ;ﾉ 
a┌ﾐIデｷﾗﾐ;ﾉ ｴ┌ﾏ;ﾐ ﾐW┌ヴﾗﾐ;ﾉ ﾐWデ┘ﾗヴﾆゲ ｷﾐ ┌ﾐIﾗﾏヮヴWゲゲWS ﾉﾗ┘どSWﾐゲｷデ┞ WﾉWIデヴﾗゲヮ┌ﾐ aｷHWヴ ゲI;aaﾗﾉSゲく N;ﾐﾗﾏWSｷIｷﾐW ϮϬϭϳ͕ ヱン 
ふヴぶが ヱヵヶンどヱヵΑンく 
ヱヰく W;ﾐｪが Sくき  G┌が )くき  W;ﾐｪが )くき  CｴWﾐが Xくき  C;ﾗが Lくき  C;ｷが Lくき  Lｷが Qくき  WWｷが Jくき  Sｴｷﾐが Jく Wくき S┌が Jくが Iﾐaﾉ┌WﾐIWゲ ﾗa 
ﾏWゲﾗヮﾗヴﾗ┌ゲ ﾏ;ｪﾐWゲｷ┌ﾏ I;ﾉIｷ┌ﾏ ゲｷﾉｷI;デW ﾗﾐ ﾏｷﾐWヴ;ﾉｷ┣;デｷﾗﾐが SWｪヴ;S;Hｷﾉｷデ┞が IWﾉﾉ ヴWゲヮﾗﾐゲWゲが I┌ヴI┌ﾏｷﾐ ヴWﾉW;ゲW aヴﾗﾏ ﾏ;Iヴﾗど
ﾏWゲﾗヮﾗヴﾗ┌ゲ ゲI;aaﾗﾉSゲ ﾗa ｪﾉｷ;Sｷﾐ H;ゲWS HｷﾗIﾗﾏヮﾗゲｷデWゲく SIｷ RWヮ ϮϬϭϴ͕ Β ふヱぶが ヱΑヴく 
ヱヱく FWヴﾐ;ﾐSW┣ SW Gヴ;Sﾗが Gくき  KWﾉﾉWヴが Lくき  ISﾗ┌┝どGｷﾉﾉWデが Yくき  W;ｪﾐWヴが Qくき  M┌ゲゲWデが AくどMくき  BWﾐﾆｷヴ;ﾐWどJWゲゲWﾉが Nくき  
BﾗヴﾐWヴデが Fくき OaaﾐWヴが Dくが BﾗﾐW ゲ┌Hゲデｷデ┌デWゲぎ ; ヴW┗ｷW┘ ﾗa デｴWｷヴ Iｴ;ヴ;IデWヴｷゲデｷIゲが IﾉｷﾐｷI;ﾉ ┌ゲWが ;ﾐS ヮWヴゲヮWIデｷ┗Wゲ aﾗヴ ﾉ;ヴｪW HﾗﾐW 
SWaWIデゲ ﾏ;ﾐ;ｪWﾏWﾐデく Jﾗ┌ヴﾐ;ﾉ ﾗa Tｷゲゲ┌W EﾐｪｷﾐWWヴｷﾐｪ ϮϬϭϴ͕ Γく 
ヱヲく G┌ﾗが Bくき  LWｷが Bくき  Lｷが Pくき M;が Pく Xくが F┌ﾐIデｷﾗﾐ;ﾉｷ┣WS ゲI;aaﾗﾉSゲ デﾗ Wﾐｴ;ﾐIW デｷゲゲ┌W ヴWｪWﾐWヴ;デｷﾗﾐく RWｪWﾐ Bｷﾗﾏ;デWヴ ϮϬϭϱ͕ 
ヲ ふヱぶが ヴΑどヵΑく 
ヱンく C┌ﾐﾐｷaaWが Gく Mくき  C┌ヴデｷﾐが Cく Mくき  Tｴﾗﾏヮゲﾗﾐが Eく Mくき  DｷIﾆゲﾗﾐが Gく Rくき OろBヴｷWﾐが Fく Jくが CﾗﾐデWﾐデどDWヮWﾐSWﾐデ OゲデWﾗｪWﾐｷI 
RWゲヮﾗﾐゲW ﾗa N;ﾐﾗｴ┞Sヴﾗ┝┞;ヮ;デｷデWぎ Aﾐ ｷﾐ Vｷデヴﾗ ;ﾐS ｷﾐ Vｷ┗ﾗ AゲゲWゲゲﾏWﾐデ ┘ｷデｴｷﾐ Cﾗﾉﾉ;ｪWﾐどB;ゲWS SI;aaﾗﾉSゲく ACS Aヮヮﾉ M;デWヴ 
IﾐデWヴa;IWゲ ϮϬϭϲ͕ Β ふンヶぶが ヲンヴΑΑどΒΒく 
ヱヴく X┌が Tくき  Mｷゲ┣┌ﾆが Jく Mくき  )ｴ;ﾗが Yくき  S┌ﾐが Hくき Fﾗﾐｪが Hくが EﾉWIデヴﾗゲヮ┌ﾐ ヮﾗﾉ┞I;ヮヴﾗﾉ;IデﾗﾐW ンD ﾐ;ﾐﾗaｷHヴﾗ┌ゲ ゲI;aaﾗﾉS ┘ｷデｴ 
ｷﾐデWヴIﾗﾐﾐWIデWS ;ﾐS ｴｷWヴ;ヴIｴｷI;ﾉﾉ┞ ゲデヴ┌Iデ┌ヴWS ヮﾗヴWゲ aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪく AS┗;ﾐIWS ｴW;ﾉデｴI;ヴW ﾏ;デWヴｷ;ﾉゲ ϮϬϭϱ͕ ヴ 
ふヱヵぶが ヲヲンΒどヴヶく 
ヱヵく Sｴﾆ;ヴｷﾐ;が Sくき  Sｴﾆ;ヴｷﾐが Rくき  WWｷﾐｴ;ヴSデが Vくき  MWﾉﾐｷﾆが Eくき  V;I┌ﾐが Gくき  Kﾉ┌ｪWヴが Pく Jくき  Lﾗ┣;が Kくき  EヮヮﾉWが Mくき  I┗ﾉW┗が 
Sく Iくき  B;┌ﾏH;Iｴが Tくき  S┌ヴﾏWﾐW┗;が Mく Aくき S┌ヴﾏWﾐW┗が Rく Aくが ンD HｷﾗSWｪヴ;S;HﾉW ゲI;aaﾗﾉSゲ ﾗa ヮﾗﾉ┞I;ヮヴﾗﾉ;IデﾗﾐW ┘ｷデｴ ゲｷﾉｷI;デWど
Iﾗﾐデ;ｷﾐｷﾐｪ ｴ┞Sヴﾗ┝┞;ヮ;デｷデW ﾏｷIヴﾗヮ;ヴデｷIﾉWゲ aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪぎ ｴｷｪｴどヴWゲﾗﾉ┌デｷﾗﾐ デﾗﾏﾗｪヴ;ヮｴ┞ ;ﾐS ｷﾐ ┗ｷデヴﾗ ゲデ┌S┞く SIｷ 
RWヮ ϮϬϭϴ͕ Β ふヱぶが ΒΓヰΑく 
ヱヶく Cﾉ;ヴﾆWが Bくが Nﾗヴﾏ;ﾉ HﾗﾐW ;ﾐ;デﾗﾏ┞ ;ﾐS ヮｴ┞ゲｷﾗﾉﾗｪ┞く CﾉｷﾐｷI;ﾉ ﾃﾗ┌ヴﾐ;ﾉ ﾗa デｴW AﾏWヴｷI;ﾐ SﾗIｷWデ┞ ﾗa NWヮｴヴﾗﾉﾗｪ┞ ぎ CJASN 
ϮϬϬϴ͕ ン S┌ヮヮﾉ ンが SヱンヱどΓく 
ヱΑく M┌ヴ┌ｪ;ﾐが Rくき R;ﾏ;ﾆヴｷゲｴﾐ;が Sくが BｷﾗヴWゲﾗヴH;HﾉW IﾗﾏヮﾗゲｷデW HﾗﾐW ヮ;ゲデW ┌ゲｷﾐｪ ヮﾗﾉ┞ゲ;IIｴ;ヴｷSW H;ゲWS ﾐ;ﾐﾗ 
ｴ┞Sヴﾗ┝┞;ヮ;デｷデWく Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϬϰ͕ ヲヵ ふヱΑぶが ンΒヲΓどンヵく 
ヱΒく C;┌ゲ;が Fくき  NWデデｷが Pく Aくき  AﾏHヴﾗゲｷﾗが Lくき  Cｷ;ヮWデデｷが Gくき  B;ﾉSｷﾐｷが Nくき  P;ｪ;ﾐｷが Sくき  M;ヴデｷﾐｷが Dくき Gｷ┌ﾐデｷが Aくが Pﾗﾉ┞ど
WヮゲｷﾉﾗﾐどI;ヮヴﾗﾉ;IデﾗﾐWっｴ┞Sヴﾗ┝┞;ヮ;デｷデW IﾗﾏヮﾗゲｷデWゲ aﾗヴ HﾗﾐW ヴWｪWﾐWヴ;デｷﾗﾐぎ ｷﾐ ┗ｷデヴﾗ Iｴ;ヴ;IデWヴｷ┣;デｷﾗﾐ ;ﾐS ｴ┌ﾏ;ﾐ ﾗゲデWﾗHﾉ;ゲデ 
ヴWゲヮﾗﾐゲWく J BｷﾗﾏWS M;デWヴ RWゲ A ϮϬϬϲ͕ Αヶ ふヱぶが ヱヵヱどヶヲく 
ヱΓく J;┞;H;ﾉ;ﾐが Mくき  Sｴ;ﾉ┌ﾏﾗﾐが Kく Tくき  Mｷデｴ;が Mく Kくき  G;ﾐWゲ;ﾐが Kくき EヮヮﾉWが Mくが EaaWIデ ﾗa ｴ┞Sヴﾗ┝┞;ヮ;デｷデW ﾗﾐ デｴW 
HｷﾗSWｪヴ;S;デｷﾗﾐ ;ﾐS HｷﾗﾏWIｴ;ﾐｷI;ﾉ ゲデ;Hｷﾉｷデ┞ ﾗa ヮﾗﾉ┞WゲデWヴ ﾐ;ﾐﾗIﾗﾏヮﾗゲｷデWゲ aﾗヴ ﾗヴデｴﾗヮ;WSｷI ;ヮヮﾉｷI;デｷﾗﾐゲく AIデ; Bｷﾗﾏ;デWヴ 
ϮϬϭϬ͕ ヶ ふンぶが ΑヶンどΑヵく 
ヲヰく W;ﾐｪが Xくき  )ｴ;ﾐｪが Gくき  Qｷが Fくき  CｴWﾐｪが Yくき  L┌が Xくき  W;ﾐｪが Lくき  )ｴ;ﾗが Jくき )ｴ;ﾗが Bくが Eﾐｴ;ﾐIWS HﾗﾐW ヴWｪWﾐWヴ;デｷﾗﾐ 
┌ゲｷﾐｪ ;ﾐ ｷﾐゲ┌ﾉｷﾐどﾉﾗ;SWS ﾐ;ﾐﾗどｴ┞Sヴﾗ┝┞;ヮ;デｷデWっIﾗﾉﾉ;ｪWﾐっPLGA IﾗﾏヮﾗゲｷデW ゲI;aaﾗﾉSく Iﾐデ J N;ﾐﾗﾏWSｷIｷﾐW ϮϬϭϴ͕ ヱンが ヱヱΑどヱヲΑく 
ヲヱく XｷWが Cくき  L┌が Hくき  Lｷが Wくき  CｴWﾐが Fく Mくき )ｴ;ﾗが Yく Mくが TｴW ┌ゲW ﾗa I;ﾉIｷ┌ﾏ ヮｴﾗゲヮｴ;デWどH;ゲWS Hｷﾗﾏ;デWヴｷ;ﾉゲ ｷﾐ ｷﾏヮﾉ;ﾐデ 
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SWﾐデｷゲデヴ┞く J M;デWヴ SIｷ M;デWヴ MWS ϮϬϭϮ͕ ヲン ふンぶが Βヵンどヶヲく 
ヲヲく K┌ﾏ;ヴが Aくき  K;ヴｪﾗ┣;ヴが Sくき  B;ｷﾐﾗが Fくき H;ﾐが Sく Sくが ASSｷデｷ┗W M;ﾐ┌a;Iデ┌ヴｷﾐｪ MWデｴﾗSゲ aﾗヴ PヴﾗS┌Iｷﾐｪ H┞Sヴﾗ┝┞;ヮ;デｷデW ;ﾐS 
H┞Sヴﾗ┝┞;ヮ;デｷデWどB;ゲWS CﾗﾏヮﾗゲｷデW SI;aaﾗﾉSゲぎ A RW┗ｷW┘く FヴﾗﾐデｷWヴゲ ｷﾐ M;デWヴｷ;ﾉゲ ϮϬϭϵ͕ ヶが ンヱンく 
ヲンく Yﾗゲｴｷﾏﾗデﾗが Hくき  Sｴｷﾐが Yく Mくき  TWヴ;ｷが Hくき V;I;ﾐデｷが Jく Pくが A HｷﾗSWｪヴ;S;HﾉW ﾐ;ﾐﾗaｷHWヴ ゲI;aaﾗﾉS H┞ WﾉWIデヴﾗゲヮｷﾐﾐｷﾐｪ ;ﾐS ｷデゲ 
ヮﾗデWﾐデｷ;ﾉ aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪく Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϬϯ͕ ヲヴ ふヱヲぶが ヲヰΑΑどヲヰΒヲく 
ヲヴく S;┘┞Wヴが Aく Aくき  Sﾗﾐｪが Sく Jくき  S┌ゲ;ﾐデﾗが Eくき  Cｴ┌;ﾐが Pくき  L;ﾏが Cく Xく Fくき  WﾗﾗSヴ┌aaが Mく Aくき  H┌デﾏ;IｴWヴが Dく Wくき Cﾗﾗﾉが 
Sく Mくが TｴW ゲデｷﾏ┌ﾉ;デｷﾗﾐ ﾗa ｴW;ﾉｷﾐｪ ┘ｷデｴｷﾐ ; ヴ;デ I;ﾉ┗;ヴｷ;ﾉ SWaWIデ H┞ ﾏPCLにTCPっIﾗﾉﾉ;ｪWﾐ ゲI;aaﾗﾉSゲ ﾉﾗ;SWS ┘ｷデｴ ヴｴBMPどヲく 
Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϬϵ͕ ンヰ ふヱンぶが ヲヴΑΓどヲヴΒΒく 
ヲヵく Wﾗﾃデﾗ┘ｷI┣が Aく Mくき  SｴWﾆ;ヴ;ﾐが Aくき  OWゲデが Mく Eくき  D┌ヮﾗﾐデが Kく Mくき  TWﾏヮﾉWﾏ;ﾐが Kく Lくき  H┌デﾏ;IｴWヴが Dく Wくき  
G┌ﾉSHWヴｪが Rく Eくき G;ヴIｹ;が Aく Jくが Cﾗ;デｷﾐｪ ﾗa Hｷﾗﾏ;デWヴｷ;ﾉ ゲI;aaﾗﾉSゲ ┘ｷデｴ デｴW Iﾗﾉﾉ;ｪWﾐどﾏｷﾏWデｷI ヮWヮデｷSW GFOGER aﾗヴ HﾗﾐW SWaWIデ 
ヴWヮ;ｷヴく Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϭϬ͕ ンヱ ふΓぶが ヲヵΑヴどヲヵΒヲく 
ヲヶく W;ﾐｪが Cくき  )ｴ;ﾗが Qくき W;ﾐｪが Mくが Cヴ┞ﾗｪWﾐｷI ンD ヮヴｷﾐデｷﾐｪ aﾗヴ ヮヴﾗS┌Iｷﾐｪ ｴｷWヴ;ヴIｴｷI;ﾉ ヮﾗヴﾗ┌ゲ ;ﾐS ヴｴBMPどヲどﾉﾗ;SWS C;ど
PっPLLA ﾐ;ﾐﾗIﾗﾏヮﾗゲｷデW ゲI;aaﾗﾉSゲ aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪく Bｷﾗa;HヴｷI;デｷﾗﾐ ϮϬϭϳ͕ Γ ふヲぶが ヰヲヵヰンヱく 
ヲΑく C;ﾗが Hくき K┌Hﾗ┞;ﾏ;が Nくが A HｷﾗSWｪヴ;S;HﾉW ヮﾗヴﾗ┌ゲ IﾗﾏヮﾗゲｷデW ゲI;aaﾗﾉS ﾗa PGAっHWデ;どTCP aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪく 
BﾗﾐW ϮϬϭϬ͕ ヴヶ ふヲぶが ンΒヶどΓヵく 
ヲΒく Y;ﾗが Qくき  CﾗゲﾏWが Jく Gくき  X┌が Tくき  Mｷゲ┣┌ﾆが Jく Mくき  PｷIIｷ;ﾐｷが Pく Hくき  Fﾗﾐｪが Hくき S┌ﾐが Hくが TｴヴWW SｷﾏWﾐゲｷﾗﾐ;ﾉ WﾉWIデヴﾗゲヮ┌ﾐ 
PCLっPLA HﾉWﾐS ﾐ;ﾐﾗaｷHヴﾗ┌ゲ ゲI;aaﾗﾉSゲ ┘ｷデｴ ゲｷｪﾐｷaｷI;ﾐデﾉ┞ ｷﾏヮヴﾗ┗WS ゲデWﾏ IWﾉﾉゲ ﾗゲデWﾗｪWﾐｷI SｷaaWヴWﾐデｷ;デｷﾗﾐ ;ﾐS Iヴ;ﾐｷ;ﾉ HﾗﾐW 
aﾗヴﾏ;デｷﾗﾐく Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϭϳ͕ ヱヱヵが ヱヱヵどヱヲΑく 
ヲΓく L;ｷが Yくき  Lｷが Yくき  C;ﾗが Hくき  Lﾗﾐｪが Jくき  W;ﾐｪが Xくき  Lｷが Lくき  Lｷが Cくき  Jｷ;が Qくき  TWﾐｪが Bくき  T;ﾐｪが Tくき  PWﾐｪが Jくき  Eｪﾉｷﾐが Dくき  
Aﾉｷﾐｷが Mくき  Gヴｷﾃヮﾏ;が Dく Wくき  RｷIｴ;ヴSゲが Gくき Qｷﾐが Lくが OゲデWﾗｪWﾐｷI ﾏ;ｪﾐWゲｷ┌ﾏ ｷﾐIﾗヴヮﾗヴ;デWS ｷﾐデﾗ PLGAっTCP ヮﾗヴﾗ┌ゲ ゲI;aaﾗﾉS 
H┞ ンD ヮヴｷﾐデｷﾐｪ aﾗヴ ヴWヮ;ｷヴｷﾐｪ Iｴ;ﾉﾉWﾐｪｷﾐｪ HﾗﾐW SWaWIデく Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϭϵ͕ ヱΓΑが ヲヰΑどヲヱΓく 
ンヰく GWﾐデｷﾉWが Pくき  Cｴｷﾗﾐﾗが Vくき  C;ヴﾏ;ｪﾐﾗﾉ;が Iくき H;デデﾗﾐが Pく Vくが Aﾐ ﾗ┗Wヴ┗ｷW┘ ﾗa ヮﾗﾉ┞ふﾉ;IデｷIどIﾗどｪﾉ┞IﾗﾉｷIぶ ;IｷS ふPLGAぶどH;ゲWS 
Hｷﾗﾏ;デWヴｷ;ﾉゲ aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪく Iﾐデ J Mﾗﾉ SIｷ ϮϬϭϰ͕ ヱヵ ふンぶが ンヶヴヰどヵΓく 
ンヱく TｴWｷﾐどH;ﾐが Wく Wくき Mｷゲヴ;が Rく Dくが BｷﾗﾏｷﾏWデｷI Iｴｷデﾗゲ;ﾐどﾐ;ﾐﾗｴ┞Sヴﾗ┝┞;ヮ;デｷデW IﾗﾏヮﾗゲｷデW ゲI;aaﾗﾉSゲ aﾗヴ HﾗﾐW デｷゲゲ┌W 
WﾐｪｷﾐWWヴｷﾐｪく AIデ; Bｷﾗﾏ;デWヴ ϮϬϬϵ͕ ヵ ふヴぶが ヱヱΒヲどΓΑく 
ンヲく HW┞S;ヴｷが )くき  MﾗｴWHHｷどK;ﾉｴﾗヴｷが Dくき Aa;ヴ;ﾐｷが Mく Sくが EﾐｪｷﾐWWヴWS WﾉWIデヴﾗゲヮ┌ﾐ ヮﾗﾉ┞I;ヮヴﾗﾉ;IデﾗﾐW ふPCLぶっﾗIデ;I;ﾉIｷ┌ﾏ 
ヮｴﾗゲヮｴ;デW ふOCPぶ ゲI;aaﾗﾉS aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪく M;デWヴ SIｷ Eﾐｪ C M;デWヴ Bｷﾗﾉ Aヮヮﾉ ϮϬϭϳ͕ Βヱが ヱヲΑどヱンヲく 
ンンく L┌ﾗが Wくき  )ｴ;ﾐｪが Sくき  L;ﾐが Yくき  H┌;ﾐｪが Cくき  W;ﾐｪが Cくき  L;ｷが Xくき  CｴWﾐが Hくき Aﾗが Nくが ンD ヮヴｷﾐデWS ヮﾗヴﾗ┌ゲ 
ヮﾗﾉ┞I;ヮヴﾗﾉ;IデﾗﾐWっﾗ┞ゲデWヴ ゲｴWﾉﾉ ヮﾗ┘SWヴ ふPCLっOSPぶ ゲI;aaﾗﾉSゲ aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪく M;デWヴｷ;ﾉゲ RWゲW;ヴIｴ E┝ヮヴWゲゲ ϮϬϭϴ͕ 
ヵ ふヴぶく 
ンヴく B;ｷ;が Lく Vくき  Sﾗ┌┣;が Wく Cくき  SW Sﾗ┌┣;が Rく Jく Fくき  VWﾉﾗゲﾗが Cく Oくき  Cｴｷ;ヴﾗが Sく Sく Xくき Fｷｪ┌WｷヴWSﾗが Mく Aく Gくが RWﾏﾗ┗;ﾉ ﾗa 
S┌ﾉa┌ヴ ;ﾐS NｷデヴﾗｪWﾐ Cﾗﾏヮﾗ┌ﾐSゲ aヴﾗﾏ DｷWゲWﾉ Oｷﾉ H┞ ASゲﾗヴヮデｷﾗﾐ Uゲｷﾐｪ Cﾉ;┞ゲ ;ゲ ASゲﾗヴHWﾐデゲく EﾐWヴｪ┞ わ F┌Wﾉゲ ϮϬϭϳ͕ ンヱ ふヱヱぶが 
ヱヱΑンヱどヱヱΑヴヲく 
ンヵく )ｴﾗ┌が Xくき  H┌;ﾐｪが Xくき  XｷWが Aくき  L┌ﾗが Sくき  Y;ﾗが Cくき  Lｷが Xくき )┌ﾗが Sくが VヲOヵどSWIﾗヴ;デWS MﾐどFWっ;デデ;ヮ┌ﾉｪｷデW I;デ;ﾉ┞ゲデ ┘ｷデｴ 
ｴｷｪｴ SOヲ デﾗﾉWヴ;ﾐIW aﾗヴ SCR ﾗa NO┝ ┘ｷデｴ NHン ;デ ﾉﾗ┘ デWﾏヮWヴ;デ┌ヴWく CｴWﾏｷI;ﾉ EﾐｪｷﾐWWヴｷﾐｪ Jﾗ┌ヴﾐ;ﾉ ϮϬϭϳ͕ ンヲヶが ヱヰΑヴどヱヰΒヵく 
ンヶく Lｷが Xくき  )ｴ┌が Wくき  L┌が Xくき  )┌ﾗが Sくき  Y;ﾗが Cくき Nｷが Cくが IﾐデWｪヴ;デWS ﾐ;ﾐﾗゲデヴ┌Iデ┌ヴWゲ ﾗa CWOヲっ;デデ;ヮ┌ﾉｪｷデWっｪどCンNヴ ;ゲ 
WaaｷIｷWﾐデ I;デ;ﾉ┞ゲデ aﾗヴ ヮｴﾗデﾗI;デ;ﾉ┞デｷI SWゲ┌ﾉa┌ヴｷ┣;デｷﾗﾐぎ MWIｴ;ﾐｷゲﾏが ﾆｷﾐWデｷIゲ ;ﾐS ｷﾐaﾉ┌WﾐIｷﾐｪ a;Iデﾗヴゲく CｴWﾏｷI;ﾉ EﾐｪｷﾐWWヴｷﾐｪ 
Jﾗ┌ヴﾐ;ﾉ ϮϬϭϳ͕ ンヲヶが ΒΑどΓΒく 
ンΑく F┌が Mくき  Lｷが Xくき  Jｷ;ﾐｪが Rくき )ｴ;ﾐｪが )くが OﾐWどSｷﾏWﾐゲｷﾗﾐ;ﾉ ﾏ;ｪﾐWデｷI ﾐ;ﾐﾗIﾗﾏヮﾗゲｷデWゲ ┘ｷデｴ ;デデ;ヮ┌ﾉｪｷデWゲ ;ゲ デWﾏヮﾉ;デWゲぎ 
Gヴﾗ┘デｴが aﾗヴﾏ;デｷﾗﾐ ﾏWIｴ;ﾐｷゲﾏ ;ﾐS ﾏ;ｪﾐWデｷI ;ﾉｷｪﾐﾏWﾐデく AヮヮﾉｷWS S┌ヴa;IW SIｷWﾐIW ϮϬϭϴ͕ ヴヴヱが ヲンΓどヲヵヰく 
ンΒく XｷWが Xくき  PWｷが Fくき  W;ﾐｪが Hくき  T;ﾐが )くき  Y;ﾐｪが )くき K;ﾐｪが Pくが II;ヴｷｷﾐぎ A ヮヴﾗﾏｷゲｷﾐｪ ﾗゲデWﾗｷﾐS┌Iデｷ┗W Iﾗﾏヮﾗ┌ﾐS aﾗヴ 
ヴWヮ;ｷヴｷﾐｪ HﾗﾐW SWaWIデ ;ﾐS ﾗゲデWﾗﾐWIヴﾗゲｷゲく J Bｷﾗﾏ;デWヴ Aヮヮﾉ ϮϬϭϱ͕ ンヰ ふンぶが ヲΓヰどΓく 
ンΓく V;ゲｴｷゲデｴが Pくき BWﾉﾉ;ヴWが Jく Rくが DW┗WﾉﾗヮﾏWﾐデ ﾗa ｴ┞HヴｷS ゲI;aaﾗﾉS ┘ｷデｴ HｷﾗﾏｷﾏWデｷI ンD ;ヴIｴｷデWIデ┌ヴW aﾗヴ HﾗﾐW ヴWｪWﾐWヴ;デｷﾗﾐく 
N;ﾐﾗﾏWSｷIｷﾐW ϮϬϭϴ͕ ヱヴ ふヴぶが ヱンヲヵどヱンンヶく 
ヴヰく W;ﾐｪが )くき  )ｴ;ﾗが Yくき  L┌ﾗが Yくき  W;ﾐｪが Sくき  SｴWﾐが Mくき  Tﾗﾏ=ゲが Hくき  )ｴ┌が Mくき Sｴｷが Xくが Aデデ;ヮ┌ﾉｪｷデWどSﾗヮWS 
WﾉWIデヴﾗゲヮ┌ﾐ ヮﾗﾉ┞ふﾉ;IデｷIどIﾗどｪﾉ┞IﾗﾉｷI ;IｷSぶ ﾐ;ﾐﾗaｷHWヴゲ Wﾐ;HﾉW Wﾐｴ;ﾐIWS ﾗゲデWﾗｪWﾐｷI SｷaaWヴWﾐデｷ;デｷﾗﾐ ﾗa ｴ┌ﾏ;ﾐ ﾏWゲWﾐIｴ┞ﾏ;ﾉ 
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ゲデWﾏ IWﾉﾉゲく RSC AS┗;ﾐIWゲ ϮϬϭϱ͕ ヵ ふヴぶが ヲンΒンどヲンΓヱく 
ヴヱく R┌SWヴﾏ;ﾐが Gくき  MﾗｪｷﾉﾐWヴが Iく Gくき  Tﾗﾉﾗゲ;が Eく Jくき  M;ゲゲ;が Nくき  G;ヴ;┗;ｪﾉｷ;が Mくき GヴｷｪWヴ;が Jく Rくが OヴSWヴWS Iﾗﾉﾉ;ｪWﾐ 
ﾏWﾏHヴ;ﾐWゲぎ ヮヴﾗS┌Iデｷﾗﾐ ;ﾐS Iｴ;ヴ;IデWヴｷ┣;デｷﾗﾐく J Bｷﾗﾏ;デWヴ SIｷ Pﾗﾉ┞ﾏ ES ϮϬϭϮ͕ ヲン ふヶぶが Βヲンどンヲく 
ヴヲく S;ﾐ┣が Mくき  LﾗヴWﾐ┣ﾗが Rくき  Aヴ;ﾐS;が Jく Jくき  M;ヴデｷﾐが Cくき Oヴゲｷﾐｷが Mくが CﾉｷﾐｷI;ﾉ W┗;ﾉ┌;デｷﾗﾐ ﾗa ; ﾐW┘ Iﾗﾉﾉ;ｪWﾐ ﾏ;デヴｷ┝ 
ふM┌Iﾗｪヴ;aデ ヮヴﾗデﾗデ┞ヮWぶ デﾗ Wﾐｴ;ﾐIW デｴW ┘ｷSデｴ ﾗa ﾆWヴ;デｷﾐｷ┣WS デｷゲゲ┌W ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ aｷ┝WS ヮヴﾗゲデｴWデｷI ヴWゲデﾗヴ;デｷﾗﾐゲぎ ; 
ヴ;ﾐSﾗﾏｷ┣WS ヮヴﾗゲヮWIデｷ┗W IﾉｷﾐｷI;ﾉ デヴｷ;ﾉく J Cﾉｷﾐ PWヴｷﾗSﾗﾐデﾗﾉ ϮϬϬϵ͕ ンヶ ふヱヰぶが ΒヶΒどΑヶく 
ヴンく Kｷﾏが Cく Sくき  J┌ﾐｪが Kく Hくき  Kｷﾏが Hくき  Kｷﾏが Cく Bくき K;ﾐｪが Iく Kくが Cﾗﾉﾉ;ｪWﾐどｪヴ;aデWS ヮﾗヴﾗ┌ゲ HDPEっPEAA ゲI;aaﾗﾉSゲ aﾗヴ HﾗﾐW 
ヴWIﾗﾐゲデヴ┌Iデｷﾗﾐく Bｷﾗﾏ;デWヴ RWゲ ϮϬϭϲ͕ ヲヰが ヲンく 
ヴヴく Cﾗヴデｷ┣ﾗが Aく Mくき  R┌SWヴﾏ;ﾐが Gくき  M;┣┣ｷﾐｷが Fく Nくき  Mﾗﾉｷﾐ┌W┗ﾗが Mく Sくき MﾗｪｷﾉﾐWヴが Iく Gくが Nﾗ┗Wﾉ V;ﾐ;Sｷ┌ﾏどLﾗ;SWS 
OヴSWヴWS Cﾗﾉﾉ;ｪWﾐ SI;aaﾗﾉS PヴﾗﾏﾗデWゲ OゲデWﾗIｴﾗﾐSヴ;ﾉ DｷaaWヴWﾐデｷ;デｷﾗﾐ ﾗa BﾗﾐW M;ヴヴﾗ┘ PヴﾗｪWﾐｷデﾗヴ CWﾉﾉゲく Iﾐデ J Bｷﾗﾏ;デWヴ ϮϬϭϲ͕ 
ヲヰヱヶが ヱヴΒヶンヵヰく 
ヴヵく S;Sｷ;ゲ;が Aくき  Nｪ┌┞Wﾐが Tく Hくき LWWが Bく Tくが Iﾐ ┗ｷデヴﾗ ;ﾐS ｷﾐ ┗ｷ┗ﾗ W┗;ﾉ┌;デｷﾗﾐ ﾗa ヮﾗヴﾗ┌ゲ PCLどPLLA ンD ヮﾗﾉ┞ﾏWヴ ゲI;aaﾗﾉSゲ 
a;HヴｷI;デWS ┗ｷ; ゲ;ﾉデ ﾉW;Iｴｷﾐｪ ﾏWデｴﾗS aﾗヴ HﾗﾐW デｷゲゲ┌W WﾐｪｷﾐWWヴｷﾐｪ ;ヮヮﾉｷI;デｷﾗﾐゲく Jﾗ┌ヴﾐ;ﾉ ﾗa Hｷﾗﾏ;デWヴｷ;ﾉゲ ゲIｷWﾐIWく Pﾗﾉ┞ﾏWヴ 
WSｷデｷﾗﾐ ϮϬϭϰ͕ ヲヵ ふヲぶが ヱヵヰどヶΑく 
ヴヶく Lｷ┗;ﾆが Kく Jくき SIｴﾏｷデデｪWﾐが Tく Dくが Aﾐ;ﾉ┞ゲｷゲ ﾗa ヴWﾉ;デｷ┗W ｪWﾐW W┝ヮヴWゲゲｷﾗﾐ S;デ; ┌ゲｷﾐｪ ヴW;ﾉどデｷﾏW ケ┌;ﾐデｷデ;デｷ┗W PCR ;ﾐS デｴW ヲふど
DWﾉデ; DWﾉデ; CふTぶぶ MWデｴﾗSく MWデｴﾗSゲ ϮϬϬϭ͕ ヲヵ ふヴぶが ヴヰヲどΒく 
ヴΑく K;ヴ;ｪWﾗヴｪｷﾗ┌が Vくき K;ヮﾉ;ﾐが Dくが Pﾗヴﾗゲｷデ┞ ﾗa ンD Hｷﾗﾏ;デWヴｷ;ﾉ ゲI;aaﾗﾉSゲ ;ﾐS ﾗゲデWﾗｪWﾐWゲｷゲく Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϬϱ͕ ヲヶ ふヲΑぶが 
ヵヴΑヴどΓヱく 
ヴΒく Sﾗﾐｪが Wくき  Y┌が Xくき  M;ヴﾆWﾉが Dく Cくき  Sｴｷが Tくき RWﾐが Wくが Cﾗ;┝ｷ;ﾉ PCLっPVA WﾉWIデヴﾗゲヮ┌ﾐ ﾐ;ﾐﾗaｷHWヴゲぎ ﾗゲゲWﾗｷﾐデWｪヴ;デｷﾗﾐ 
Wﾐｴ;ﾐIWヴ ;ﾐS IﾗﾐデヴﾗﾉﾉWS Sヴ┌ｪ ヴWﾉW;ゲW SW┗ｷIWく Bｷﾗa;HヴｷI;デｷﾗﾐ ϮϬϭϯ͕ ヵ ふンぶが ヰンヵヰヰヶく 
ヴΓく KWﾉﾉWヴが Lくき  RWｪｷWﾉどF┌デ┞ヴ;が Aくき  GｷﾏWﾐﾗが Mくき  E;ヮが Sくき  MWﾐSﾗ┣;が Gくき  AﾐSヴW┌が Vくき  W;ｪﾐWヴが Qくき  K┞┣ｷﾗﾉが Aくき  
SWH;ゲデｷ;ﾐが Vくき  SデﾗIｴWﾉが Gくき  Aヴヴ┌WHﾗが Mくき BWﾐﾆｷヴ;ﾐWどJWゲゲWﾉが Nくが Cｴｷデﾗゲ;ﾐどH;ゲWS ﾐ;ﾐﾗIﾗﾏヮﾗゲｷデWゲ aﾗヴ デｴW ヴWヮ;ｷヴ ﾗa HﾗﾐW 
SWaWIデゲく N;ﾐﾗﾏWSｷIｷﾐW ϮϬϭϳ͕ ヱン ふΑぶが ヲヲンヱどヲヲヴヰく 
ヵヰく Iﾐ┣;ﾐ;が Jく Aくき  Oﾉ┗Wヴ;が Dくき  F┌ﾉﾉWヴが Sく Mくき  KWﾉﾉ┞が Jく Pくき  Gヴ;W┗Wが Oく Aくき  SIｴ┘;ヴ┣が Eく Mくき  K;デWゲが Sく Lくき A┘;Sが Hく Aくが 
ンD ヮヴｷﾐデｷﾐｪ ﾗa IﾗﾏヮﾗゲｷデW I;ﾉIｷ┌ﾏ ヮｴﾗゲヮｴ;デW ;ﾐS Iﾗﾉﾉ;ｪWﾐ ゲI;aaﾗﾉSゲ aﾗヴ HﾗﾐW ヴWｪWﾐWヴ;デｷﾗﾐく Bｷﾗﾏ;デWヴｷ;ﾉゲ ϮϬϭϰ͕ ンヵ ふヱンぶが 
ヴヰヲヶどンヴく 
ヵヱく XｷWが Yくき  L;ﾐが Xく Rくき  B;ﾗが Rく Yくき  LWｷが Yくき  C;ﾗが )く Qくき  Y;ﾐｪが Mく Bくき  Y;ﾐｪが Wくき W;ﾐｪが Yく Bくが HｷｪｴどヮWヴaﾗヴﾏ;ﾐIW 
ヮﾗヴﾗ┌ゲ ヮﾗﾉ┞ﾉ;IデｷSW ゲデWヴWﾗIﾗﾏヮﾉW┝ Iヴ┞ゲデ;ﾉﾉｷデW ゲI;aaﾗﾉSゲ ヮヴWヮ;ヴWS H┞ ゲﾗﾉ┌デｷﾗﾐ HﾉWﾐSｷﾐｪ ;ﾐS ゲ;ﾉデ ﾉW;Iｴｷﾐｪく M;デWヴ SIｷ Eﾐｪ C 
M;デWヴ Bｷﾗﾉ Aヮヮﾉ ϮϬϭϴ͕ Γヰが ヶヰヲどヶヰΓく 
 
